IE33054B1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
IE33054B1
IE33054B1 IE437/69A IE43769A IE33054B1 IE 33054 B1 IE33054 B1 IE 33054B1 IE 437/69 A IE437/69 A IE 437/69A IE 43769 A IE43769 A IE 43769A IE 33054 B1 IE33054 B1 IE 33054B1
Authority
IE
Ireland
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
IE437/69A
Other versions
IE33054L (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IE33054L publication Critical patent/IE33054L/en
Publication of IE33054B1 publication Critical patent/IE33054B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IE437/69A 1968-04-16 1969-03-31 Heterocyclic compounds IE33054B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1789568 1968-04-16
GB5078868 1968-10-25
GB5866668 1968-12-10

Publications (2)

Publication Number Publication Date
IE33054L IE33054L (en) 1969-10-16
IE33054B1 true IE33054B1 (en) 1974-03-06

Family

ID=27257551

Family Applications (1)

Application Number Title Priority Date Filing Date
IE437/69A IE33054B1 (en) 1968-04-16 1969-03-31 Heterocyclic compounds

Country Status (9)

Country Link
JP (1) JPS4913789B1 (en)
BE (1) BE731549A (en)
CH (1) CH515231A (en)
DE (1) DE1919381B2 (en)
FR (1) FR2007466A1 (en)
IE (1) IE33054B1 (en)
IL (1) IL31991A (en)
NL (1) NL6905846A (en)
SE (1) SE366038B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377248A (en) * 1972-04-25 1974-12-11 Ici Ltd Furan derivatives
FR2421897A1 (en) * 1978-04-04 1979-11-02 Labaz Alpha substd. 3-thienyl:acetamide derivs. - useful as hypnotic, anticonvulsant and tranquillising agents
FR2537138A1 (en) * 1982-12-03 1984-06-08 Roussel Uclaf PROCESS FOR THE PREPARATION OF ACETIC 2-THIOPHENE ACID DERIVATIVES
FR2537137B1 (en) * 1982-12-03 1985-07-19 Roussel Uclaf PROCESS FOR THE PREPARATION OF ACETIC 2-THIOPHENE ACID DERIVATIVES AND INTERMEDIATE PRODUCTS NECESSARY FOR THEIR PREPARATION
FR2578253B1 (en) * 1985-03-01 1987-05-22 Roussel Uclaf NOVEL PRODUCTS DERIVED FROM THIENYL 2-MALONIC ACID, THEIR PREPARATION PROCESS AND THEIR APPLICATION
US5240956A (en) * 1990-11-07 1993-08-31 Cortech, Inc. Ester inhibitors
NZ240442A (en) * 1990-11-07 1994-11-25 Cortech Inc 2-heterocyclic substituted aliphatic carboxylic acid esters of (optionally substituted) phenol and pharmaceutical compositions
WO1996002529A1 (en) * 1994-07-13 1996-02-01 Taisho Pharmaceutical Co., Ltd. Thiopheneacetic acid derivative
US11739082B2 (en) 2017-08-31 2023-08-29 Ahammune Biosciences Private Limited Thiophene compounds, process for synthesis and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449368A (en) * 1964-12-30 1969-06-10 Merck & Co Inc Heterocyclic aliphatic acids
GB1139164A (en) * 1966-12-05 1969-01-08 Parke Davis & Co New heterocyclic acetic acid compounds and methods for their production

Also Published As

Publication number Publication date
DE1919381B2 (en) 1974-05-16
BE731549A (en) 1969-10-15
IL31991A (en) 1971-12-29
IE33054L (en) 1969-10-16
DE1919381A1 (en) 1969-10-23
IL31991A0 (en) 1969-06-25
NL6905846A (en) 1969-10-20
JPS4913789B1 (en) 1974-04-03
FR2007466A1 (en) 1970-01-09
DE1919381C3 (en) 1975-02-06
SE366038B (en) 1974-04-08
CH515231A (en) 1971-11-15

Similar Documents

Publication Publication Date Title
IE33906B1 (en) Pyrrolobenzodiazepinone derivatives
CY886A (en) Heterocyclic azaspiroalkanediones
MY7500209A (en) Pyridobenzo-diazepine derivatives
IL37749A0 (en) Heterocyclic compounds
MY7500263A (en) Heterocyclic compounds
IL32786A (en) N-phenylsuccinimide derivatives
IL32640A0 (en) 3-carbamoylphenoxy-1-amino-2-propanol derivatives
CA939342A (en) Heterocyclic compounds
CA948199A (en) Heterocyclic compounds
IE33054B1 (en) Heterocyclic compounds
ZA707762B (en) Heterocyclic compounds
ZA715698B (en) Heterocyclic compounds
IL32309A0 (en) New pyrazolodiazepinone compounds
PH10255A (en) Quinoline derivatives compounds
ZA708344B (en) Heterocyclic compounds
ZA715697B (en) Heterocyclic compounds
MY7400293A (en) Ergolene derivatives
IL31887A (en) 1-cycloalkylmethyl-3-phenyl-pyrrolidine compounds
MY7300335A (en) Halophenylalkylguanidine compounds
ZM4369A1 (en) Organic compounds
MY7400140A (en) Oxazinobenzodiazepine derivatives
ZA695832B (en) New heterocyclic compounds
CA802216A (en) Heterocyclic compounds
IE32843L (en) Penicillin derivatives
IL31796A0 (en) Heterocyclic compounds